LEADER 01522nam  2200409Ia 450 
001 9910696912703321
005 20230902161609.0
035   $a(CKB)5470000002383769
035   $a(OCoLC)567444113
035   $a(EXLCZ)995470000002383769
100   $a20100323d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eIND meetings for human drugs and biologics, chemistry, manufacturing, and controls information
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2001]
215   $a1 electronic resource (10 pages)
300   $a"CMC."
300   $a"May 2001."
320   $aIncludes bibliographical references (page 10).
517   $aGuidance for industry 
606   $aMedicine, Experimental$xGovernment policy$zUnited States
606   $aBiologicals$zUnited States
606   $aDrug approval$zUnited States
615  0$aMedicine, Experimental$xGovernment policy
615  0$aBiologicals
615  0$aDrug approval
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696912703321
996   $aGuidance for industry$93434577
997   $aUNINA